AstraZeneca (NYSE:AZN) is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the top five pharmaceutical companies in the world with healthcare sales of over $18.8 billion and leading positions in sales of gastrointestinal, oncology, cardiovascular, neuroscience and respiratory products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global and European) as well as the FTSE4Good Index. Worldwide, AstraZeneca has six major research and development sites, four discovery facilities and a clinical research site. With more than 100 years of combined experience, scientists at AstraZeneca have discovered and developed many of today's leading prescription medicines-pharmaceuticals which contribute to a higher quality of life for millions of patients and to a better health economy worldwide.

Since 1886, the Johnson & Johnson Family of Companies continue to provide innovative health care products that improve or save lives. A shared system of values, known as Our Credo, serves as a guide for all who are part of the Johnson & Johnson Family of Companies and can be found in 36 languages. Our Corporate Contributions program serves as a lifeline for Social Responsibility initiatives in communities in which we live and work around the world. In addition, our worldwide Environmental Commitment demonstrates how we live up to our Credo responsibility to protect our natural resources.The Johnson & Johnson Family of Companies offer challenging job opportunities to people looking for career growth in an environment that recognizes and rewards achievement based on performance -- not on an organization-wide, predetermined standard.

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec's significant products that address diseases such as multiple sclerosis (MS), lymphoma and rheumatoid arthritis. Biogen Idec is headquartered in Cambridge, Massachusetts, with international headquarters in Zug, Switzerland. We have additional offices in the U.S., Canada, Australia, Japan and throughout Europe. Biogen Idec attracts world-class talent to fuel its global growth, and the company currently employs more than 4,200 people worldwide. Explore the possibilities at Biogen Idec and learn how you can contribute to our mission of transforming discovery into care. We welcome your expertise, your insight and your enthusiasm to bring new hope to patients worldwide.

At the heart of Daiichi Sankyo is the fundamental belief that each employee helps shape our success. We have created an exceptional working environment that values and rewards individual contributions, but we also believe in the power of collaboration. We provide employees with the training, tools, and technology that they need to excel. Our open communication, emphasis on results, and spirit of personal accountability are hallmarks of our corporate culture and ensure that each employee's unique abilities are valued and utilized. Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan's second largest pharmaceutical company and a global leader in pharmaceutical innovation since 1899. At Daiichi Sankyo, we believe that good science walks hand-in-hand with humanity. The company is dedicated to the discovery, development and commercialization of innovative medicines that improve the lives of patients throughout the world.

At Novartis Oncology, our employees worldwide share a common mission: discover and develop innovative medicines to fight cancer. Headquartered in Florham Park, New Jersey, we are passionate about providing a broad range of new remedies and practical solutions that change the way patients live with cancer. With more than 4,500 employees operating in over 50 countries, Novartis Oncology has a truly global reach. We have the advantage of extraordinarily talented and globally diverse employees who, through shared goals and different perspectives, are dedicated to improving and extending the lives of patients around the world. We have a proven track record of providing new and improved cancer treatments and are continually discovering and developing new therapies that change lives. We are currently concentrating efforts on research platforms spanning discoveries in signal transduction inhibition, cytotoxic agents, antiangiogenesis, cell cyle/apoptosis, iron chelation, metastases and hormone therapy.

Astellas is the brightest spot in the pharmaceutical industry; not only because of what we do, but also how we do it. If you are looking for a company where you can change a life, make a dream come true and light the way for a changing tomorrow, Astellas is the place where you can shine! At Astellas, we are driven by our core competencies of a High Sense of Ethics, Customer Focus, Creativity and a Competitive Focus. Astellas strives to be the company of choice among all our stakeholders, including our customers, our shareholders, our employees, and the global community. To achieve this goal, we will go beyond all others in exploring and tapping the potential of the life sciences and by supporting healthy living for people around the world. Our Business Philosophy is to contribute toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.

At BD, we are committed to helping all people live healthy lives. BD (Becton, Dickinson and Company) is a global medical technology company focused on improving drug therapy, enhancing the diagnosis of infectious diseases, and advancing drug discovery. BD manufactures and sells medical supplies, devices, laboratory instruments, antibodies, reagents and diagnostic products through its three segments: BD Medical, BD Diagnostics and BD Biosciences. We serve healthcare institutions, life science researchers, clinical laboratories, industry, and the general public. BD is headquartered in the United States and has offices in nearly 50 countries worldwide. BD aspires to become a great company by improving medical care around the world through innovative enhancements to medical technology, by delivering great financial performance, and by making BD a great place to work.

Agilent Technologies Life Sciences and Chemical Analysis (LSCA) is a leading provider of instrumentation, supplies, software and services to the life sciences. Agilent’s 25,000+ customers range from global pharmaceutical corporations to biotech companies, government labs and academic researchers. With $1.4 billion in revenue, Agilent LSCA has 4,100 employees worldwide and provides global sales, support and manufacturing. LSCA’s major sites are located in California, Delaware, Shanghai, Tokyo and Germany. Agilent tools help scientists to understand complex biological processes, unlock the causes of disease and speed the discovery of new drugs. Agilent provides products for customer needs throughout the entire pharmaceutical value chain from basic research to drug manufacturing.

IPM is a non-profit product development partnership (PDP) established in 2002 to prevent HIV transmission by accelerating the development and availability of a safe and effective microbicide for use by women in developing countries. IPM is committed to providing women with an affordable and self-initiated HIV- prevention strategy to reduce the cycle of infection which has led to the deaths of more than 25 million people worldwide and orphaned more than 15 million children since 1981. Like the promise of a future AIDS vaccine, microbicides represent an essential component of an integrated and comprehensive global response to the HIV/AIDS epidemic.IPM also funds, co-funds or leverages resources to support the drug development projects of other entities. In some cases, however, the most efficient approach is for IPM, itself, to take the lead in developing, testing and conducting clinical trials of promising microbicide compounds.

Sanofi pasteur is the largest company in the world devoted entirely to vaccines. Each year, we produce more than 1.4 billion doses of vaccine, making it possible to protect 500 million people across the globe, which is about 1.4 million per day. The company offers the broadest range of vaccines, providing protection against 20 bacterial and viral diseases. During the 2004-2005 Influenza season, sanofi pasteur was the sole supplier of injectable influenza vaccine to the US market. We believe there is still much work to be done. As the vaccines business of the sanofi-aventis Group, the world’s third largest pharmaceutical company, we have access to the resources needed to continue our boundary-breaking innovations far into the future. Come join a company making a strong impact on world health. Our location offers the best year-round sports and recreational activities, as well as close proximity to the cultural and educational attractions of Philadelphia and New York City.

Millennium is committed to making a difference in people's lives by developing breakthrough treatments for important diseases. Our researchers focus on serious disorders, examining in minute detail every step of the disease process to discover the underlying mechanisms at work, and to determine how those mechanisms may differ from one person to another. With this knowledge, we hope to provide patients with the most effective medicines for them, ensuring that they receive the right drugs, directed toward the right disease targets. We call this approach Personalized Medicine. At Millennium we set the highest standards of performance, behavior, and responsibility, both for ourselves as individuals and for the Company as a whole. Our standards today are the same as they were when the Company was founded, as reflected in our core values, and we back up those words with actions, as evidenced with our emphasis on corporate and social responsibility.

Teva Pharmaceuticals USA is a leading generic pharmaceutical company, marketing products from a wide range of therapeutic areas including analgesic, anti-infective, cardiovascular, oncology, CNS, dermatological and anti-inflammatory. Dosage forms include extended and immediate release tablets and capsules, injectables, creams, ointments, solutions, and suspensions. Teva USA products are marketed to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies.Teva USA has an aggressive Research and Development effort and one of the best overall ANDA approval records in the industry. The company's mission is to play a leading role in the transformation of the U.S. healthcare system through its preeminence in the development, manufacture and marketing of generic pharmaceuticals.

Radiometer is the world leader in the development, manufacture and distribution of technologically advanced critical care testing systems for blood gas, electrolytes and metabolites. Radiometer America Inc., a division of Danaher Corporation (a Fortune 200 company and one of Forbes' Most Admired Companies), is the world's leading provider of blood gas instruments and support services. Our equipment includes a broad line of analyzers, blood samplers, quality control systems, and IT solutions. Radiometer provides hospitals worldwide with STAT-testing solutions for the diagnosis of critically ill patients, from laboratory to point-of-care test settings. We are expanding our business arena into cardiac diagnostics with a new innovative measuring instrument within acute care testing. Due to our ongoing growth, we are looking to fill a number of positions.

Otologics LLC is a medical device company dedicated to enhancing the quality of life of the moderate to severely hearing impaired by developing and marketing surgically implantable devices designed to enable effective communication. Otologic’s products address a large global market of hearing impaired individuals whose needs are not currently being met by available products. Our products are currently available in European markets and are in Phase II Clinical Trials in the United States. Otologics is an equal opportunity employer. The Company is committed to ensuring that all decisions regarding recruitment, hiring, promotion, assignment, training, termination, and other matters are made without unlawful discrimination on the basis of race, color, citizenship, national origin, ancestry, sex, sexual orientation, religion, age, physical or mental disability, marital status or any other factor which cannot lawfully be used as a basis for an employment decision.

Celsis International plc is a world leading provider of innovative life science products and laboratory services to the pharmaceutical, biopharmaceutical, and consumer products industries through its three business areas; rapid detection, analytical and drug development services and ADME-Tox in vitro technologies. The company is listed on the London Stock Exchange (CEL.L). Each division of Celsis International plc has the capacity to deliver substantial time and cost savings to its customers, in addition to ensuring product quality and safety for consumers. Using proprietary technology, the Celsis Rapid Detection division provides diagnostic systems for the rapid detection of contamination.These systems provide significant economic value by reducing the time it takes to test and release raw materials, in process and finished goods to market. Celsis Analytical Services division provides cost effective outsourced laboratory testing services to pharmaceutical and biopharmaceutical companies.

Encorium is a full-service Contract Research Organization (CRO) providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development. Our teams are intimately familiar with the nuances of complex study design and the conduct of clinical trials from pre-clinical development through to phase IV and post marketing. Whether you require support for your early phase development plan, superior responsive project management and clinical site monitoring, advanced biostatistical support, practical, efficient solutions to data management issues or world-class medical/scientific consultancy, Encorium has the right people and resources to accelerate your product development.

As a global leader in healthcare, we are committed to offering our customers the very best life-enhancing products. As an employer, we’re equally intent on attracting and retaining the very best people. People who believe in creating a better future, and have the skills, energy and imagination to achieve it. Being one of the major employers in the pharmaceutical industry, we offer our dedicated professionals the scope, freedom and support to make things happen. Talented people from every background around the globe have the opportunity to exchange insights and expertise freely – across different specialties and different countries. However diverse their perspectives and backgrounds, our employees share a common belief—that we can make the future better in our continuous quest to help millions of people lead longer, healthier and happier lives.

Here at Merck, we rally around the statement made in 1950 by George W. Merck, the son of our founder, - "We try never to forget that medicine is for the people. It is not for the profits." And so, we're looking for people who will help us carry out our mission - preserving and improving human life.Our business is preserving and improving human life. All of our actions must be measured by our success in achieving this goal. We value, above all, our ability to serve everyone who can benefit from the appropriate use of our products and services, thereby providing lasting consumer satisfaction. We are committed to the highest standards of ethics and integrity. We are responsible to our customers, to Merck employees and their families, to the environments we inhabit, and to the societies we serve worldwide. In discharging our responsibilities, we do not take professional or ethical shortcuts.

The National Institute of Allergy and Infectious Diseases (NIAID), part of the world-renowned National Institutes of Health, strives to understand, treat, and ultimately prevent the myriad of infectious, immunologic, and allergic diseases. We seek to match ideal candidates with numerous positions as we assimilate unprecedented funding and mobilize science to protect public health. Whether you are a scientist, nurse, health specialist, or have a background in other support disciplines such as finance, communications, and administration, your individual talents are needed to support our mission. Build your career at NIAID and work with some of the most talented investigators in this country and abroad who are committed to improve global health in the 21st century. The DHHS, NIH, NIAID offers unique training and career building opportunities, competitive salaries and a comprehensive benefits package.

At the New Schering-Plough, we aspire to earn the trust of doctors, patients and customers by providing a steady flow of innovative, science-based medicines and services that improve the health and well-being of people around the world. To achieve these goals and grow our company, we are working to earn the trust of all stakeholders. We understand that earning trust demands hard work, sharp execution, integrity and transparency. Our customers and patients are our most important constituents. Our vision for the New Schering-Plough clearly sets forth what we will do as a global team, what makes us special as a company and what will give us a competitive advantage.To become the best, we are getting back to basics and reinventing our company by driving positive change. We are focused on becoming the best in three key strategic areas: people, products and processes. We will continue to build a work environment where people want to succeed, where they are able to succeed and where they are allowed to succeed. A "success environment" enables hard-working professionals to thrive, grow and achieve great things.

Stryker is a broadly based, global leader in medical technology that consistently delivers exceptional results. We are one of the largest players in the $28.6 billion worldwide orthopaedic market and our products improve medical professionals’ and patients’ lives in over 120 countries. We are a company that sets high standards. Our growth has come from offering an unparalleled variety of innovative, high-quality products and services resulting from the dedication of our employees. Through better products, simplified surgical techniques and improved hospital efficiencies, we are reducing health-care costs in systems throughout the world and helping patients regain their active lives.

Virginia Bioinformatics Institute (VBI), a Commonwealth of Virginia shared resource established at Virginia Tech in July 2000, serves as a flagship bioinformatics research institute wedding cutting-edge biological research with state-of-the-art computer science. Used synergistically in a diversified research portfolio, these tools catalyze new knowledge and economic development for the Commonwealth of Virginia and beyond. The Institute's esteemed faculty and staff encourage research collaboration to increase the understanding of molecular, cellular, and environmental interactions that affect human health, agricultural systems, and the environment.